These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11035253)

  • 1. Immunodetection of NAD(P)H:quinone oxidoreductase 1 (NQO1) in human tissues.
    Siegel D; Ross D
    Free Radic Biol Med; 2000 Aug; 29(3-4):246-53. PubMed ID: 11035253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical detection of NAD(P)H:quinone oxidoreductase in human lung and lung tumors.
    Siegel D; Franklin WA; Ross D
    Clin Cancer Res; 1998 Sep; 4(9):2065-70. PubMed ID: 9748120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical localization of NQO1 in epithelial dysplasia and neoplasia and in donor eyes.
    Schelonka LP; Siegel D; Wilson MW; Meininger A; Ross D
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1617-22. PubMed ID: 10845577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase 1.
    Siegel D; McGuinness SM; Winski SL; Ross D
    Pharmacogenetics; 1999 Feb; 9(1):113-21. PubMed ID: 10208650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NAD(P)H: quinone oxidoreductase 1 expression in human bone marrow endothelial cells.
    Siegel D; Ryder J; Ross D
    Toxicol Lett; 2001 Dec; 125(1-3):93-8. PubMed ID: 11701227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical localization of NAD(P)H:quinone oxidoreductase in conjunctival melanomas and primary acquired melanosis.
    Wilson MW; Schelonka LP; Siegel D; Meininger A; Ross D
    Curr Eye Res; 2001 May; 22(5):348-52. PubMed ID: 11600935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NAD(P)H:quinone oxidoreductase-1 overexpression predicts poor prognosis in small cell lung cancer.
    Cui X; Jin T; Wang X; Jin G; Li Z; Lin L
    Oncol Rep; 2014 Dec; 32(6):2589-95. PubMed ID: 25231218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absolute quantification of NAD(P)H:quinone oxidoreductase 1 in human tumor cell lines and tissues by liquid chromatography-mass spectrometry/mass spectrometry using both isotopic and non-isotopic internal standards.
    Tang Z; Wu M; Li Y; Zheng X; Liu H; Cheng X; Xu L; Wang G; Hao H
    Anal Chim Acta; 2013 Apr; 772():59-67. PubMed ID: 23540248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcellular localization of NAD(P)H:quinone oxidoreductase 1 in human cancer cells.
    Winski SL; Koutalos Y; Bentley DL; Ross D
    Cancer Res; 2002 Mar; 62(5):1420-4. PubMed ID: 11888914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase).
    Traver RD; Siegel D; Beall HD; Phillips RM; Gibson NW; Franklin WA; Ross D
    Br J Cancer; 1997; 75(1):69-75. PubMed ID: 9000600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and genetic analysis of NAD(P)H:quinone oxidoreductase 1 (NQO1).
    Siegel D; Kepa JK; Ross D
    Curr Protoc Toxicol; 2007; Chapter 4():Unit4.22. PubMed ID: 23045144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.
    Jamieson D; Wilson K; Pridgeon S; Margetts JP; Edmondson RJ; Leung HY; Knox R; Boddy AV
    Clin Cancer Res; 2007 Mar; 13(5):1584-90. PubMed ID: 17332305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An alternatively spliced form of NQO1 (DT-diaphorase) messenger RNA lacking the putative quinone substrate binding site is present in human normal and tumor tissues.
    Gasdaska PY; Fisher H; Powis G
    Cancer Res; 1995 Jun; 55(12):2542-7. PubMed ID: 7780966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of NQO1 overexpression for prognostic evaluation of gastric adenocarcinoma.
    Lin L; Qin Y; Jin T; Liu S; Zhang S; Shen X; Lin Z
    Exp Mol Pathol; 2014 Apr; 96(2):200-5. PubMed ID: 24384455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human dioxin-inducible NAD(P)H: quinone oxidoreductase cDNA-encoded protein expressed in COS-1 cells is identical to diaphorase 4.
    Shaw PM; Reiss A; Adesnik M; Nebert DW; Schembri J; Jaiswal AK
    Eur J Biochem; 1991 Jan; 195(1):171-6. PubMed ID: 1899380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The NAD(P)H:quinone oxidoreductase locus in human colon carcinoma HCT 116 cells resistant to mitomycin C.
    Hu LT; Stamberg J; Pan S
    Cancer Res; 1996 Nov; 56(22):5253-9. PubMed ID: 8912865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of an isogenic human colon tumor model for NQO1 gene expression: application to investigate the role of DT-diaphorase in bioreductive drug activation in vitro and in vivo.
    Sharp SY; Kelland LR; Valenti MR; Brunton LA; Hobbs S; Workman P
    Mol Pharmacol; 2000 Nov; 58(5):1146-55. PubMed ID: 11040064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NAD(P)H: quinone oxidoreductase 1 expression in kidney podocytes.
    Zappa F; Ward T; Pedrinis E; Butler J; McGown A
    J Histochem Cytochem; 2003 Mar; 51(3):297-302. PubMed ID: 12588957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new screening system for NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones: identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent.
    Winski SL; Hargreaves RH; Butler J; Ross D
    Clin Cancer Res; 1998 Dec; 4(12):3083-8. PubMed ID: 9865924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of NAD(P)H:quinone oxidoreductase 1 is increased along with NF-kappaB p105/p50 in human cutaneous melanomas.
    Cheng Y; Li J; Martinka M; Li G
    Oncol Rep; 2010 Apr; 23(4):973-9. PubMed ID: 20204281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.